Tag Archives: scores

Pfizer’s COVID-19 vaccine scores FDA nod in adolescents, enabling a wider rollout

In a first for the U.S., the FDA has authorized the use of Pfizer’s BioNTech-partnered COVID-19 vaccine for use in adolescents between the ages of 12 and 15—months ahead of the upcoming school year in the fall.  The FDA will amend the existing emergency authorization for the vaccine, which was first issued in December, the agency said. Pfizer’s… Read More »

Years after Cubist buyout, Merck scores a new Zerbaxa indication. Can it jump-start sales?

Merck hasn’t exactly made a fortune on its $ 9.5 billion Cubist Pharmaceuticals buyout, but now, a next-gen antibiotic it acquired in that deal has a brand-new indication that could help jump-start sales. On Monday, the FDA approved that drug, Zerbaxa, to treat adults with hospital-acquired and ventilator-associated pneumonia. It’s an add-on to Zerbaxa’s original approvals—to treat complicated… Read More »